{
  "meta": {
    "title": "Inicet_Nov_2024",
    "url": "https://brainandscalpel.vercel.app/inicet-nov-2024-a1c05038.html",
    "scrapedAt": "2025-11-30T07:35:31.338Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">1- Retinal Pigment Epithelium, 2 - Outer nuclear layer, 3 - Inner plexiform layer, 4 - Ganglion layer </span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">1- Retinal Pigment Epithelium, 2 - Inner nuclear layer, 3 - Outer plexiform layer, 4 - Ganglion layer  </span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">1- Ganglion layer, 2 - Inner nuclear layer, 3 - Outer plexiform layer, 4 - Retinal Pigment Epithelium  </span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">1- Ganglion layer, 2 - Outer plexiform layer, 3 - Inner nuclear layer, 4 - Retinal Pigment Epithelium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following parts of the retina are marked correctly?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503110f36e2bc-7bda-410c-a0a7-5ce42e2255cb.jpg\"></span></p>",
      "unique_key": "DT1318074",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318074,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Microscopic Structure of the Retina:</strong></p>\r\n<p>The retina has 10 layers, divided into two parts: the pigment epithelium and the neurosensory retina, with a potential space in between.</p>\r\n<ol>\r\n<li><strong>Pigment Epithelium</strong>: Outer layer of the retina, consisting of a single layer of pigment cells. It supports the neurosensory retina and acts as an antireflective layer. The interphotoreceptor matrix (IPM) binds the two layers.</li>\r\n<li><strong>Rods and Cones</strong>: Photoreceptor cells for vision. Rods are responsible for peripheral and low-light vision, while cones are responsible for central, color, and high-resolution vision.</li>\r\n<li><strong>External Limiting Membrane</strong>: A membrane allowing the passage of rod and cone processes.</li>\r\n<li><strong>Outer Nuclear Layer</strong>: Contains the nuclei of rods and cones.</li>\r\n<li><strong>Outer Plexiform Layer</strong>: Contains synapses between rods, cones, bipolar cells, and horizontal cells.</li>\r\n<li><strong>Inner Nuclear Layer</strong>: Contains bipolar, horizontal, amacrine, and Muller&rsquo;s cell bodies, as well as capillaries of the central retinal artery.</li>\r\n<li><strong>Inner Plexiform Layer</strong>: Contains synapses between bipolar cell axons, ganglion cell dendrites, and amacrine cells.</li>\r\n<li><strong>Ganglion Cell Layer</strong>: Contains ganglion cell bodies, which are second-order neurons. Two types exist: midget ganglion cells (macula region) and polysynaptic ganglion cells (peripheral retina).</li>\r\n<li><strong>Nerve Fibre Layer</strong>: Made up of axons from ganglion cells, forming the optic nerve.</li>\r\n<li><strong>Internal Limiting Membrane</strong>: The innermost layer separating the retina from the vitreous, formed by Muller&rsquo;s cell expansions.</li>\r\n</ol>\r\n<p><strong>Fovea Centralis:</strong></p>\r\n<ul>\r\n<li>Contains tightly packed cones; rods are absent.</li>\r\n<li>The central part (foveola) consists mostly of cone nuclei, with other retinal layers absent.</li>\r\n</ul>\r\n<p><strong>Functional Divisions:</strong></p>\r\n<ul>\r\n<li>The retina is divided into temporal and nasal regions.</li>\r\n<li>Nerve fibres from the temporal retina go to the same side&rsquo;s geniculate body, while those from the nasal retina cross at the optic chiasm and reach the opposite geniculate body.</li>\r\n<li>The geniculate body neurons are the third-order neurons in the visual pathway.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503114190971a-4370-4543-b0dd-61fe02fb1efb.jpg\">\r\n<p><strong>Reference: </strong><a href=\"https://www.nature.com/articles/s41433-021-01437-w\">https://www.nature.com/articles/s41433-021-01437-w</a></p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Iris and pupil will both be visible </span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Only pupillary margin is visible </span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Iris details are visible</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\"> Iris and pupillary margin are not visible</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about macular opacity?</span></p>",
      "unique_key": "DT1318075",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318075,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503112fa375e4-5cf5-46e8-960e-b7069483b0b1.jpg\"><br><p><strong>Corneal Opacity:</strong></p>\r\n<p>Corneal opacity refers to the loss of transparency of the cornea, typically due to scarring. It can result from various conditions, such as congenital anomalies, healed corneal wounds, or ulcers.</p>\r\n<p><strong>Causes:</strong></p>\r\n<ol>\r\n<li><strong>Congenital opacities</strong> from developmental issues or birth trauma.</li>\r\n<li><strong>Healed corneal wounds</strong>.</li>\r\n<li><strong>Healed corneal ulcers</strong>.</li>\r\n</ol>\r\n<p><strong>Clinical Features:</strong></p>\r\n<ul>\r\n<li>Loss of vision if opacity covers the pupil.</li>\r\n<li>Blurred vision due to astigmatism.</li>\r\n</ul>\r\n<p><strong>Types of Corneal Opacity:</strong></p>\r\n<ol>\r\n<li><strong>Nebular Opacity</strong>: Faint opacity affecting the Bowman&rsquo;s layer and superficial stroma. It causes blurred vision due to irregular astigmatism.</li>\r\n<li><strong>Macular Opacity</strong>: Semi-dense opacity affecting about half the corneal stroma.</li>\r\n<li><strong>Leucomatous Opacity</strong>: Dense white opacity from scarring involving more than half the stroma.</li>\r\n<li><strong>Adherent Leucoma</strong>: Occurs after corneal perforation, causing iris incarceration.</li>\r\n<li><strong>Corneal Facet</strong>: A depression at the scar site, due to less fibrous tissue.</li>\r\n<li><strong>Keratectasia</strong>: Increased corneal curvature due to weak scar tissue.</li>\r\n<li><strong>Anterior Staphyloma</strong>: An ectasia caused by sloughing of the cornea, leaving the iris behind the scar.</li>\r\n</ol>\r\n<p><strong>Secondary Changes in Long-Standing Cases:</strong></p>\r\n<ul>\r\n<li>Hyaline and calcareous degeneration</li>\r\n<li>Pigmentation</li>\r\n<li>Atheromatous ulceration</li>\r\n</ul>\r\n<p><strong>Treatment Options:</strong></p>\r\n<ol>\r\n<li><strong>Optical Iridectomy</strong>: For central macular or leucomatous opacities, improving vision with pupillary dilation.</li>\r\n<li><strong>Phototherapeutic Keratectomy (PTK)</strong>: Uses excimer laser for superficial nebular opacities.</li>\r\n<li><strong>Keratoplasty</strong>: A transplant for uncomplicated cases where iridectomy isn't effective.</li>\r\n<li><strong>Cosmetic Contact Lenses</strong>: Best for non-vision-recoverable eyes with scars.</li>\r\n<li><strong>Tattooing of the Scar</strong>: For cosmetic purposes in eyes without vision potential. Gold or platinum is used to color the scar after epithelium removal.</li>\r\n</ol>\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<p><strong>Choice A: Iris and pupil will both be visible (Incorrect)</strong></p>\r\n<ul>\r\n<li>In macular opacity, the <strong>iris is obscured</strong> due to the semi-dense scarring.</li>\r\n<li>The <strong>entire pupil is not clearly visible</strong>, only the margin may be seen.</li>\r\n</ul>\r\n<p><strong>Choice C: Iris details are visible (Incorrect)</strong></p>\r\n<ul>\r\n<li>Macular opacity is <strong>not transparent enough</strong> to allow visualization of fine iris details.</li>\r\n</ul>\r\n<p><strong>Choice D: Iris and pupillary margin are not visible (Incorrect)</strong></p>\r\n<ul>\r\n<li>This would be true for <strong>leucomatous opacity</strong>, which is <strong>denser than macular opacity</strong> and blocks all visibility of iris and pupil.</li>\r\n</ul>\r\n<h4><strong>Key Takeaway:</strong></h4>\r\n<p>Macular opacity partially obstructs light, allowing visibility of only the pupillary margin (Choice B).</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior staphyloma </span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinoschisis</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Tractional retinal detachment </span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Progressive myopia </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a complication of diabetic retinopathy?</span></p>",
      "unique_key": "DT1318080",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318080,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Classification of Diabetic Retinopathy (DR)</strong></p>\r\n<p>Diabetic Retinopathy (DR) is a complication of diabetes that affects the retina, leading to vision impairment. It is classified into several stages based on the severity of the retinal changes observed.</p>\r\n<p><strong>I.Non-Proliferative Diabetic Retinopathy (NPDR)</strong></p>\r\n<p>NPDR is categorized based on the severity of retinal changes and includes:</p>\r\n<ul>\r\n<li><strong>Mild NPDR:</strong> At least one microaneurysm present.</li>\r\n<li><strong>Moderate NPDR:</strong> Microaneurysms and intraretinal hemorrhage in 2-3 quadrants, early IRMA (Intraretinal Microvascular Abnormalities), and possibly hard/soft exudates.</li>\r\n<li><strong>Severe NPDR (4-2-1 Rule):</strong> Any of the following:\r\n<ul>\r\n<li>Four quadrants of microaneurysms and extensive intraretinal hemorrhages.</li>\r\n<li>Two quadrants of venous beading.</li>\r\n<li>One quadrant of IRMA changes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Very Severe NPDR:</strong> Any two of the following:\r\n<ul>\r\n<li>Four quadrants of microaneurysms and extensive intraretinal hemorrhages.</li>\r\n<li>Two quadrants of venous beading.</li>\r\n<li>One quadrant of IRMA changes.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>Risk factors for progression to <strong>Proliferative Diabetic Retinopathy (PDR)</strong> include the presence of IRMAs, multiple intraretinal hemorrhages, venous beading, and widespread capillary non-perfusion.</p>\r\n<p><strong>II.Proliferative Diabetic Retinopathy (PDR)</strong></p>\r\n<p>PDR occurs when new blood vessels proliferate in the retina. It typically develops after 25 years of diabetes and is more common in juvenile-onset diabetes. Key features of PDR include:</p>\r\n<ul>\r\n<li><strong>Neovascularization</strong> at the optic disc (NVD) and/or elsewhere in the retina (NVE).</li>\r\n<li>The formation of <strong>fibrovascular epiretinal membranes</strong>, which can lead to vitreous hemorrhage and retinal detachment.</li>\r\n<li><strong>High-Risk Characteristics (HRCs):</strong>\r\n<ul>\r\n<li>Early PDR: NVD or NVE without HRCs.</li>\r\n<li>PDR with HRCs: NVD or NVE with vitreous hemorrhage or preretinal hemorrhage.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>III. Diabetic Maculopathy</strong></p>\r\n<p>Diabetic maculopathy involves changes in the macula, often leading to vision loss. It may be associated with NPDR or PDR. There are different types:</p>\r\n<ul>\r\n<li><strong>Clinically Significant Macular Edema (CSME):</strong> Diagnosed when one of the following is present:\r\n<ul>\r\n<li>Retinal thickening at or within 500 microns of the fovea.</li>\r\n<li>Hard exudates at or within 500 microns of the fovea with adjacent retinal thickening.</li>\r\n<li>A zone of retinal thickening one disc diameter or larger near the fovea.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Clinico-Angiographic Classification:</strong>\r\n<ol>\r\n<li><strong>Focal Exudative Maculopathy:</strong> Microaneurysms, hemorrhages, macular edema, and exudates.</li>\r\n<li><strong>Diffuse Exudative Maculopathy:</strong> Diffuse retinal edema, minimal exudates, and diffuse leakage.</li>\r\n<li><strong>Ischemic Maculopathy:</strong> Microvascular blockage, leading to loss of vision.</li>\r\n<li><strong>Mixed Maculopathy:</strong> A combination of ischemic and exudative features.</li>\r\n</ol>\r\n</li>\r\n<li><strong>OCT Classification of Diabetic Macular Edema (DME):</strong>\r\n<ol>\r\n<li><strong>Non-Tractional DME:</strong> Includes spongy macular thickening, cystoid macular edema (CME), and neurosensory detachment.</li>\r\n<li><strong>Tractional DME:</strong> Includes vitreofoveal traction (VFT) and taut/thickened posterior hyaloid membrane.</li>\r\n</ol>\r\n</li>\r\n</ul>\r\n<p><strong>IV. Advanced Diabetic Eye Disease (ADED)</strong></p>\r\n<p>This is the final stage of uncontrolled proliferative diabetic retinopathy and includes severe complications such as:</p>\r\n<ul>\r\n<li>Persistent vitreous hemorrhage.</li>\r\n<li>Tractional retinal detachment.</li>\r\n<li>Neovascular glaucoma.</li>\r\n</ul>\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<p><strong>Choice A: Posterior staphyloma (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Posterior staphyloma</strong> is a <strong>bulging of the posterior segment</strong> of the eye, typically associated with <strong>pathological myopia</strong>, not diabetic retinopathy.</li>\r\n</ul>\r\n<p><strong>Choice B: Retinoschisis (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Retinoschisis</strong> is the <strong>splitting of the retinal layers</strong>, most commonly seen in <strong>degenerative or X-linked juvenile retinoschisis</strong>, not DR.</li>\r\n</ul>\r\n<p><strong>Choice D: Progressive myopia (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Progressive myopia</strong> is a characteristic of <strong>high myopia</strong>, leading to <strong>axial elongation</strong> of the eye, but it is <strong>not a complication of diabetic retinopathy</strong>.</li>\r\n</ul>\r\n<P><strong>Key Takeaway:</strong></P>\r\n<p>Tractional retinal detachment (Choice C) is a major complication of proliferative diabetic retinopathy due to fibrovascular traction on the retina.</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute congestive glaucoma </span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic retinopathy </span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratoconus \t</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Iridocyclitis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause of bilateral sudden painless loss of vision? </span></p>",
      "unique_key": "DT1318081",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318081,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Sudden Painless Loss of Vision:</strong></p>\r\n<ul>\r\n<li>Central Retinal Artery Occlusion</li>\r\n<li>Massive Vitreous Hemorrhage</li>\r\n<li>Retinal Detachment (Macular Area)</li>\r\n<li>Ischaemic Central Retinal Vein Occlusion</li>\r\n</ul>\r\n<p><strong>Sudden Painless Defective Vision:</strong></p>\r\n<ul>\r\n<li>Central Serous Retinopathy</li>\r\n<li>Optic Neuritis</li>\r\n<li>Methyl Alcohol Amblyopia</li>\r\n<li>Non-Ischaemic Central Retinal Vein Occlusion</li>\r\n</ul>\r\n<p><strong>Sudden Painful Loss of Vision:</strong></p>\r\n<ul>\r\n<li>Acute Congestive Glaucoma (Primary/Secondary)</li>\r\n<li>Acute Iridocyclitis</li>\r\n<li>Chemical Injuries to Eyeball</li>\r\n<li>Mechanical Injuries to Eyeball</li>\r\n</ul>\r\n<p><strong>Gradual Painless Defective Vision:</strong></p>\r\n<ul>\r\n<li>Progressive Pterygium (Papillary Area)</li>\r\n<li>Corneal Degenerations &amp; Dystrophies</li>\r\n<li>Developmental/Senile Cataract</li>\r\n<li>Optic Atrophy</li>\r\n<li>Chorioretinal Degenerations</li>\r\n<li>Age-related Macular Degeneration</li>\r\n<li>Diabetic Retinopathy</li>\r\n<li>Refractive Errors</li>\r\n</ul>\r\n<p><strong>Gradual Painful Defective Vision:</strong></p>\r\n<ul>\r\n<li>Chronic Iridocyclitis</li>\r\n<li>Corneal Ulceration</li>\r\n<li>Chronic Simple Glaucoma</li>\r\n</ul>\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<p><strong>Choice A: Acute congestive glaucoma (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Acute angle-closure glaucoma</strong> causes <strong>sudden painful</strong> vision loss due to <strong>increased intraocular pressure (IOP)</strong>.</li>\r\n</ul>\r\n<p><strong>Choice C: Keratoconus (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Keratoconus</strong> is a progressive corneal thinning disorder, leading to <strong>gradual</strong> vision loss with distortion, not sudden blindness.</li>\r\n</ul>\r\n<p><strong>Choice D: Iridocyclitis (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Iridocyclitis (anterior uveitis)</strong> presents with <strong>pain, photophobia, and gradual vision blurring</strong>, not sudden painless loss of vision.</li>\r\n</ul>\r\n<P><strong>Key Takeaway:</strong></P>\r\n<p>None of the options are a perfect match for bilateral sudden painless vision loss. The most common true causes are central retinal artery occlusion (CRAO), massive vitreous hemorrhage, ischemic central retinal vein occlusion (CRVO), or macular retinal detachment.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypo-fluorescent line </span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyper-fluorescent branching </span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypo-fluorescent dot</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyper-fluorescent dot </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In FFA, the microaneurysms appear as: </span></p>",
      "unique_key": "DT1318085",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318085,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Fundus Fluorescein Angiography (FFA)</strong></p>\n<p><strong>Fundus Fluorescein Angiography (FFA)</strong> is a valuable diagnostic tool used to assess various retinal disorders by evaluating the flow of fluorescein dye through the retina and choroidal vasculature. It helps in detecting changes in the blood-retinal barrier, which can indicate conditions such as diabetic retinopathy, vascular occlusions, and more.</p>\n<p><strong>Indications for FFA</strong></p>\n<p>FFA is particularly useful for diagnosing and managing several ocular disorders:</p>\n<ol>\n<li><strong>Diabetic Retinopathy</strong> (both NPDR and PDR)</li>\n<li><strong>Vascular Occlusions</strong> (e.g., central retinal artery/vein occlusion)</li>\n<li><strong>Eales' Disease</strong></li>\n<li><strong>Central Serous Retinopathy</strong></li>\n<li><strong>Cystoid Macular Edema (CME)</strong></li>\n</ol>\n<p><strong>Contraindications for FFA</strong></p>\n<ul>\n<li><strong>Renal Impairment</strong></li>\n<li><strong>Known Allergies to Fluorescein Dye</strong></li>\n</ul>\n<p><strong>Technique of FFA</strong></p>\n<ol>\n<li><strong>Injection of Dye</strong>: A 10% sterile sodium fluorescein solution (5 mL) is injected intravenously into the antecubital vein.</li>\n<li><strong>Fundus Imaging</strong>: The patient is seated with dilated pupils. Serial fundus photographs are taken using a fundus camera, which utilizes:\n<ul>\n<li><strong>Blue Light (420&ndash;490 nm)</strong> to excite fluorescein dye in the retina and choroid.</li>\n<li><strong>Yellow-Green Filter (510&ndash;530 nm)</strong> to capture the fluorescent light emitted.</li>\n</ul>\n</li>\n<li><strong>Timing of Photographs</strong>:\n<ul>\n<li><strong>5 seconds</strong> after injection (initial image).</li>\n<li><strong>1 second intervals</strong> for the next 20 seconds.</li>\n<li><strong>Every 3-5 seconds</strong> for 1 minute.</li>\n<li><strong>10-minute post-injection</strong> image.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Complications of FFA</strong></p>\n<p>FFA is a generally safe procedure with minor side effects including:</p>\n<ul>\n<li><strong>Discoloration of skin and urine</strong></li>\n<li><strong>Mild nausea</strong> (rare vomiting)</li>\n<li><strong>Rare anaphylactic reactions</strong> or <strong>cardiorespiratory issues</strong> (requires emergency management, including dexamethasone and antihistamines)</li>\n</ul>\n<p><strong>Phases of Angiogram</strong></p>\n<p>The normal FFA angiogram consists of the following overlapping phases:</p>\n<ol>\n<li><strong>Pre-Arterial Phase</strong>:\n<ul>\n<li>Occurs immediately after the dye injection, before retinal arteries fill, showing only choroidal circulation.</li>\n</ul>\n</li>\n<li><strong>Arterial Phase</strong>:\n<ul>\n<li>Begins 1 second after the pre-arterial phase, as retinal arterioles fill with dye.</li>\n</ul>\n</li>\n<li><strong>Arteriovenous Phase</strong>:\n<ul>\n<li>In this phase, dye fills retinal arterioles and capillaries, with laminar flow along retinal veins.</li>\n</ul>\n</li>\n<li><strong>Venous Phase</strong>:\n<ul>\n<li>The veins fill, and the arterioles empty. This phase can be divided into early, mid, and late venous phases.</li>\n</ul>\n</li>\n</ol>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503118915ef75-5cbb-476c-850d-08f41de5a81b.jpg\">\n<p><strong>Abnormalities Detected by FFA</strong></p>\n<p>FFA can help identify both <strong>hyperfluorescence</strong> and <strong>hypofluorescence</strong> that indicate various retinal conditions:</p>\n<ol>\n<li><strong> Hypofluorescence</strong></li>\n</ol>\n<p>Hypofluorescence refers to areas where the dye appears less bright than expected, which could be due to:</p>\n<ul>\n<li><strong>Window Defect in RPE</strong>: Atrophy of the Retinal Pigment Epithelium (RPE), exposing the underlying choroidal fluorescence.</li>\n<li><strong>Pooling Under Detached RPE</strong>: Seen in conditions like <strong>Age-Related Macular Degeneration (ARMD)</strong>.</li>\n<li><strong>Pooling Under Sensory Retina</strong>: Caused by a breakdown in the blood-retinal barrier, as seen in <strong>Central Serous Retinopathy (CSR)</strong>.</li>\n<li><strong>Leakage in Cystoid Macular Edema (CME)</strong>: Due to breakdown of the inner blood-retinal barrier.</li>\n<li><strong>Neovascularization</strong>: Leakage from abnormal blood vessels (neovascularization) in <strong>Proliferative Diabetic Retinopathy</strong> (PDR) or subretinal neovascular membranes in ARMD.</li>\n<li><strong>Staining</strong>: Retention of dye in tissues, such as <strong>drusen</strong> in ARMD.</li>\n<li><strong>Leakage from Optic Nerve Head</strong>: Seen in <strong>papilledema</strong>.</li>\n</ul>\n<ol start=\"2\">\n<li><strong> Hyperfluorescence</strong></li>\n</ol>\n<p>Hyperfluorescence refers to areas that appear unusually bright due to excessive dye accumulation. It is caused by:</p>\n<ul>\n<li><strong>Retinal Hemorrhages and Hard Exudates</strong>: Blockage of normal background fluorescence, as seen in <strong>diabetic retinopathy</strong> and other retinal disorders.</li>\n<li><strong>Occlusion of Retinal or Choroidal Vasculature</strong>: Resulting in reduced perfusion, as seen in <strong>central retinal artery occlusion</strong> or in diabetic retinopathy.</li>\n<li><strong>Loss of Vasculature</strong>: Conditions like <strong>choroideremia</strong> and <strong>myopic degeneration</strong> lead to areas of non-perfusion or absence of blood vessels.</li>\n</ul>\n<p><strong>Microaneurysms</strong></p>\n<p>Microaneurysms are early signs of diabetic retinopathy, often found in the macular region or areas with capillary non-perfusion. They appear as small red dots on the retina and can leak fluorescein dye, which is visible on FFA. These microaneurysms are formed due to the dilation (out-pouching) of capillary walls after pericyte loss, contributing to fluid, protein, lipid, and dye leakage.</p>\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\n<p><strong>Choice A: Hypo-fluorescent line (Incorrect)</strong></p>\n<ul>\n<li>Hypo-fluorescent lines are seen in <strong>vascular occlusions or blocked fluorescence</strong>, not in microaneurysms.</li>\n</ul>\n<p><strong>Choice B: Hyper-fluorescent branching (Incorrect)</strong></p>\n<ul>\n<li>Hyper-fluorescent branching is a feature of <strong>neovascularization</strong>, where new abnormal vessels form and leak fluorescein dye.</li>\n</ul>\n<p><strong>Choice C: Hypo-fluorescent dot (Incorrect)</strong></p>\n<ul>\n<li>Hypo-fluorescent dots are typically seen in <strong>blocked fluorescence</strong> (e.g., hemorrhages) or <strong>capillary non-perfusion</strong>(ischemic areas).</li>\n</ul>\n<P><strong>Key Takeaway:</strong></P>\n<p>On FFA, microaneurysms appear as \"hyper-fluorescent dots\" due to the accumulation of fluorescein within these small, localized capillary dilations.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">1:3 </span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">2:3 </span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">1:2 </span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Normal diameter of artery to vein (AV) diameter: </span></p>",
      "unique_key": "DT1318087",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318087,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Retinal Blood Vessels:</strong></p>\r\n<ul>\r\n<li><strong>Normal Appearance:</strong>\r\n<ul>\r\n<li>Arterioles: Bright red</li>\r\n<li>Veins: Purplish</li>\r\n<li>Caliber ratio: 2:3</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Abnormalities:</strong></p>\r\n<ul>\r\n<li><strong>Narrowing of Arterioles</strong>: Seen in:\r\n<ul>\r\n<li>Hypertensive Retinopathy</li>\r\n<li>Arteriosclerosis</li>\r\n<li>Central Retinal Artery Occlusion</li>\r\n</ul>\r\n</li>\r\n<li><strong>Tortuosity of Veins</strong>: Occurs in:\r\n<ul>\r\n<li>Diabetes Mellitus</li>\r\n<li>Central Retinal Vein Occlusion</li>\r\n<li>Blood Dyscrasias</li>\r\n</ul>\r\n</li>\r\n<li><strong>Sheathing of Vessels</strong>: Seen in:\r\n<ul>\r\n<li>Periphlebitis Retinae (Eale's Disease, Sarcoidosis, Syphilis, Tuberculosis, Behcet's Disease, AIDS)</li>\r\n<li>Hypertensive Retinopathy</li>\r\n</ul>\r\n</li>\r\n<li><strong>Vascular Pulsations:</strong>\r\n<ul>\r\n<li><strong>Venous Pulsations</strong>: 10-20% of normal individuals may show pulsations near the optic disc. Can be induced by slight intraocular pressure.\r\n<ul>\r\n<li><strong>Absent in Papilloedema</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Arterial Pulsations</strong>: Always pathological, seen in:\r\n<ul>\r\n<li>Aortic Regurgitation</li>\r\n<li>Aortic Aneurysm</li>\r\n<li>Exophthalmic Goitre</li>\r\n<li><strong>Pressure Arterial Pulse</strong>: Seen in high IOP or low blood pressure, limited to optic disc.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<p><strong>Choice A: 1:3 (Incorrect)</strong></p>\r\n<ul>\r\n<li>A <strong>1:3 ratio</strong> suggests <strong>arteriolar narrowing</strong>, which can be seen in <strong>hypertensive retinopathy</strong> or <strong>arteriosclerosis</strong>.</li>\r\n</ul>\r\n<p><strong>Choice C: 1:2 (Incorrect)</strong></p>\r\n<ul>\r\n<li>A <strong>1:2 ratio</strong> is <strong>abnormal</strong> and suggests <strong>moderate to severe arteriolar narrowing</strong>, often seen in <strong>chronic hypertension</strong>.</li>\r\n</ul>\r\n<p><strong>Choice D: 1:1 (Incorrect)</strong></p>\r\n<ul>\r\n<li>A <strong>1:1 ratio</strong> indicates <strong>severe arteriolar narrowing</strong>, which is highly abnormal and associated with <strong>advanced hypertensive retinopathy</strong> or <strong>vasculopathy</strong>.</li>\r\n</ul>\r\n<P><strong>Key Takeaway:</strong></P>\r\n<p>The normal AV ratio in the retina is 2:3, where arterioles are slightly smaller than veins. Changes in this ratio can indicate vascular pathologies such as hypertension or diabetes.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Eye pain </span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Macular edema</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Purulent discharge </span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Astigmatism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In pterygium, there is: </span></p>",
      "unique_key": "DT1318089",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503110e4e35da-48b3-4458-a2f0-608955dcf60d.jpg\"><br><p><strong>Pterygium</strong></p>\r\n<p>Pterygium is a wing-shaped fold of conjunctiva that grows onto the cornea, typically in the interpalpebral fissure.</p>\r\n<p><strong>Etiology</strong><br /> While the exact cause is unclear, pterygium is more common in people living in hot climates. It&rsquo;s believed to result from prolonged exposure to environmental factors such as sun (UV rays), dry heat, wind, and dust.</p>\r\n<p><strong>Pathology</strong><br /> Pterygium is a degenerative condition where the subconjunctival tissue undergoes elastotic degeneration and forms vascularized granulation tissue. This tissue encroaches on the cornea, leading to destruction of the corneal epithelium, Bowman&rsquo;s layer, and superficial stroma.</p>\r\n<p><strong>Clinical Features</strong></p>\r\n<ul>\r\n<li><strong>Demographics</strong>: More common in older males, especially those with outdoor occupations. It can be unilateral or bilateral, usually affecting the nasal side.</li>\r\n<li><strong>Symptoms</strong>: Cosmetic discomfort, foreign body sensation, irritation, and vision issues (e.g., astigmatism or corneal involvement).</li>\r\n<li><strong>Signs</strong>: A triangular fold of conjunctiva encroaching on the cornea, typically on the nasal side. It consists of:\r\n<ul>\r\n<li><strong>Head</strong>: Apical part on the cornea</li>\r\n<li><strong>Neck</strong>: Constricted part at the limbus</li>\r\n<li><strong>Body</strong>: Scleral part between limbus and canthus</li>\r\n<li><strong>Cap</strong>: Whitish infiltrate in front of the head</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Types</strong></p>\r\n<ul>\r\n<li><strong>Progressive Pterygium</strong>: Thick, fleshy, vascular, with whitish infiltrates (Fuch&rsquo;s spots).</li>\r\n<li><strong>Regressive Pterygium</strong>: Thin, atrophic, with minimal vascularity and sometimes Stocker&rsquo;s line (iron deposition).</li>\r\n</ul>\r\n<p><strong>Complications</strong><br /> Rarely, cystic degeneration, infection, or neoplastic changes (e.g., epithelioma, fibrosarcoma, malignant melanoma) can occur.</p>\r\n<p><strong>Differential Diagnosis</strong><br /> Pterygium must be distinguished from pseudopterygium, which results from adhesions of inflamed conjunctiva to the cornea, often after chemical burns.</p>\r\n<p><strong>Incorrect Choices Explanation:</strong></p>\r\n<p><strong>Choice A: Eye pain (Incorrect)</strong></p>\r\n<ul>\r\n<li>Pterygium usually causes <strong>irritation</strong> and <strong>foreign body sensation</strong>, but it does <strong>not</strong> typically cause <strong>severe pain</strong> unless associated with <strong>inflammation</strong> or <strong>secondary infection</strong>.</li>\r\n</ul>\r\n<p><strong>Choice B: Macular edema (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Macular edema</strong> occurs in <strong>retinal conditions</strong> like <strong>diabetic retinopathy</strong> or <strong>vein occlusions</strong>, not in <strong>pterygium</strong>, which affects the <strong>conjunctiva and cornea</strong>.</li>\r\n</ul>\r\n<p><strong>Choice C: Purulent discharge (Incorrect)</strong></p>\r\n<ul>\r\n<li>Pterygium is a <strong>chronic, degenerative condition</strong>, not an infectious one. It does <strong>not</strong> produce <strong>purulent discharge </strong>like bacterial conjunctivitis.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Pterygium causes astigmatism by inducing corneal flattening, leading to visual distortion.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">EOG </span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">ERG </span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Visual Evoked Potential </span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal ERG </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the case of Best disease, which of the following is the diagnostic investigation? </span></p>",
      "unique_key": "DT1318092",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318092,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Best Disease (Vitelliform Dystrophy of the Fovea)</p>\r\n<p>Best disease is characterized by a sharply defined, usually bilateral, orange-yellow disc in the foveal region that resembles the yolk of a fried egg. Visual acuity typically remains good, and the neuroepithelium remains unaffected initially. Vision loss occurs when the lesion transitions into an irregular pigmented area, becomes \"scrambled,\" or experiences hemorrhages, leading to polymorphous foveal dystrophy.</p>\r\n<p>The vitelliform disc is believed to be located in the pigment epithelium and contains viscous, homogeneous material.</p>\r\n<p>Clinical Features</p>\r\n<ul>\r\n<li>Visual Fields: Normal except for a central scotoma.</li>\r\n<li>Dark Adaptation &amp; Electroretinogram (ERG): Both remain normal.</li>\r\n<li>Electrooculogram (EOG): Pathological.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250311f29ea009-e6a1-477a-b9b4-972d43f03822.jpg\">\r\n<p><strong>Incorrect Choices Explanation:</strong></p>\r\n<p><strong>Choice B: ERG (Electroretinogram) (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>ERG is normal</strong> in Best disease, as photoreceptor function remains <strong>intact</strong> in early stages.</li>\r\n<li>ERG is useful in conditions like <strong>Retinitis Pigmentosa</strong>, but not in diagnosing Best disease.</li>\r\n</ul>\r\n<p><strong>Choice C: Visual Evoked Potential (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>VEP</strong> assesses <strong>optic nerve function</strong> and is used for conditions like <strong>optic neuritis or demyelinating diseases (e.g., multiple sclerosis)</strong>.</li>\r\n<li>It has <strong>no role</strong> in diagnosing <strong>Best disease</strong>, which is a <strong>retinal disorder</strong>.</li>\r\n</ul>\r\n<p><strong>Choice D: Multifocal ERG (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Multifocal ERG</strong> helps evaluate <strong>localized retinal dysfunction</strong> but is <strong>not a primary diagnostic tool</strong> for Best disease.</li>\r\n<li><strong>EOG remains the gold standard</strong> for diagnosis.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Best disease is diagnosed using EOG, which shows a reduced Arden ratio, while ERG remains normal.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Viscoelastic causes mechanical injury to corneal endothelium</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">It prevents the anterior chamber from collapsing during crucial steps like capsulorhexis and IOL placement</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">It is inert and can be left behind after surgery </span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Silicone oil, perfluoropropane, and sodium hexafluoride are most commonly   used</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about viscoelastic substances?\r\n</span></p>",
      "unique_key": "DT1318097",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318097,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250311d09c296f-bd64-4d82-8477-6a9c36d76302.jpg\"><br><p><strong>Viscoelastics (Viscosurgical Devices)</strong></p>\n<p>Viscoelastics are inert, non-toxic fluids used in intraocular surgeries to assist the surgeon. They help maintain spaces within the eye, manipulate tissues, isolate eye compartments, and protect delicate structures like the corneal endothelium. These devices are classified as either cohesive or dispersive based on their properties.</p>\n<ul>\n<li><strong>Cohesive Viscoelastics</strong>: These molecules adhere to each other, making them ideal for tissue manipulation, maintaining space, and easy removal. They are especially useful for <strong>capsulorhexis</strong> and <strong>intraocular lens</strong> placement\n<ul>\n<li>Example: <strong>Sodium hyaluronate 1%</strong> - High molecular weight, excellent space maintenance, and easy removal.</li>\n</ul>\n</li>\n<li><strong>Dispersive Viscoelastics</strong>: These molecules coat ocular surfaces, remaining in place during irrigation and protecting structures like the corneal endothelium, particularly during <strong>phacoemulsification</strong>.\n<ul>\n<li>Example: <strong>4% chondroitin sulfate + 3% sodium hyaluronate</strong> - Low molecular weight, provides tissue protection and space maintenance.</li>\n</ul>\n</li>\n<li><strong>Other Types</strong>:\n<ul>\n<li><strong>Hypermellose 2%</strong>: Less viscous than sodium hyaluronate, used to coat lenses and instruments during cataract surgery.</li>\n<li><strong>Methylcellulose 3%</strong>: Another variant used in similar applications.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Viscoelastic causes mechanical injury to corneal endothelium (Incorrect)</strong></p>\n<ul>\n<li>Viscoelastic substances <strong>protect</strong> the <strong>corneal endothelium</strong> rather than causing injury.</li>\n<li>However, <strong>incomplete removal</strong> post-surgery may lead to <strong>increased intraocular pressure (IOP)</strong>.</li>\n</ul>\n<p><strong>Choice C: It is inert and can be left behind after surgery (Incorrect)</strong></p>\n<ul>\n<li>Viscoelastics are <strong>not completely inert</strong> and should be <strong>removed</strong> after surgery.</li>\n<li>Retention may cause <strong>postoperative IOP elevation</strong> or <strong>inflammation</strong>.</li>\n</ul>\n<p><strong>Choice D: Silicone oil, perfluoropropane, and sodium hexafluoride are most commonly used (Incorrect)</strong></p>\n<ul>\n<li>These are <strong>tamponade agents</strong>, not viscoelastic substances:\n<ul>\n<li><strong>Silicone oil</strong> is used in <strong>retinal detachment surgery</strong>.</li>\n<li><strong>Perfluoropropane (C3F8) &amp; sulfur hexafluoride (SF6)</strong> are used in <strong>pneumatic retinopexy</strong>.</li>\n</ul>\n</li>\n<li><strong>Viscoelastic substances</strong> include <strong>sodium hyaluronate, chondroitin sulfate, and methylcellulose</strong>.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Viscoelastics prevent anterior chamber collapse during cataract surgery, aiding in IOL placement and protecting ocular structures.</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">History taking </span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Vision measurement </span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Copious irrigation of eyes </span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Administration of pain killers </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A worker presented with a history of 'chuna' (lime) falling in both his eyes a few hours back. What is the first immediate management? \r\n\r\n</span></p>",
      "unique_key": "DT1318101",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318101,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Chemical Injuries</strong></p>\n<p>Chemical injuries can range from minor irritation to complete loss of vision, with the severity dependent on the type of chemical and its exposure duration.</p>\n<p><strong>Causes</strong><br /> Chemical injuries typically result from:</p>\n<ol>\n<li>Domestic accidents (e.g., ammonia, solvents, cosmetics)</li>\n<li>Agricultural accidents (e.g., fertilizers, insecticides)</li>\n<li>Laboratory accidents (e.g., acids, alkalis)</li>\n<li>Deliberate attacks (e.g., acid attacks)</li>\n<li>Chemical warfare</li>\n<li>Self-inflicted injuries (e.g., in malingerers)</li>\n</ol>\n<p><strong>Types of Chemical Injuries</strong></p>\n<ul>\n<li><strong>Alkali Burns</strong>: The most severe, caused by substances like lime, caustic soda, and ammonia. They cause deep tissue penetration, resulting in widespread necrosis and difficulty in circumscribing damage. The stages include:\n<ol>\n<li><strong>Acute Ischemic Necrosis</strong>: Conjunctival edema, corneal sloughing, iris inflammation.</li>\n<li><strong>Reparation</strong>: Regeneration of conjunctival and corneal epithelium.</li>\n<li><strong>Complications</strong>: Symblepharon, corneal ulceration, cataract, and glaucoma.</li>\n</ol>\n</li>\n<li><strong>Acid Burns</strong>: Less severe but still dangerous, caused by sulfuric, hydrochloric, or nitric acids. Acid burns cause protein coagulation, creating a protective barrier.\n<ul>\n<li>Conjunctival necrosis, sloughing, and symblepharon formation occur.</li>\n<li>Corneal damage ranges from opacification to potential corneal sloughing.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Grading of Chemical Burns (Roper-Hall Classification)</strong></p>\n<ul>\n<li><strong>Grade I</strong>: Clear cornea, no limbal ischemia &ndash; Excellent prognosis</li>\n<li><strong>Grade II</strong>: Hazy cornea, iris visible, &lt;1/3 limbal ischemia &ndash; Good prognosis</li>\n<li><strong>Grade III</strong>: Opaque cornea, iris obscured, 1/3 to 1/2 limbal ischemia &ndash; Guarded prognosis</li>\n<li><strong>Grade IV</strong>: Opaque cornea, no iris view, &gt;1/2 limbal ischemia &ndash; Poor prognosis</li>\n</ul>\n<p><strong>Treatment of Chemical Burns</strong></p>\n<ol>\n<li><strong>Immediate Actions</strong>:\n<ul>\n<li><strong>Irrigation</strong>: Flush the eye with clean water or saline for 20-30 minutes until pH normalizes.</li>\n<li><strong>Remove Contaminants</strong>: Use a swab stick to remove particles, especially from lime.</li>\n<li><strong>Excise Necrotic Tissue</strong>: Remove damaged conjunctiva and corneal epithelium.</li>\n</ul>\n</li>\n<li><strong>Maintenance</strong>:\n<ul>\n<li><strong>Topical Antibiotics</strong> (e.g., moxifloxacin) to prevent infection.</li>\n<li><strong>Steroid Eye Drops</strong> (with caution after 2 weeks) to reduce inflammation.</li>\n<li><strong>Cycloplegics</strong> (e.g., atropine) for comfort.</li>\n<li><strong>Ascorbic Acid</strong> to improve wound healing.</li>\n<li><strong>Lubricant Eye Drops</strong> to promote healing.</li>\n<li><strong>Autologous Serum</strong> for epithelial healing and growth factors.</li>\n<li><strong>Sodium Citrate</strong> to stabilize neutrophils and reduce collagenase.</li>\n<li><strong>Doxycycline</strong> for collagenase inhibition.</li>\n</ul>\n</li>\n<li><strong>Prevention of Complications</strong>:\n<ul>\n<li><strong>Symblepharon Prevention</strong>: Use a glass shell or sweep a glass rod in the fornices twice daily.</li>\n<li><strong>Secondary Glaucoma</strong>: Treated with timolol and acetazolamide.</li>\n<li><strong>Limbal Stem Cell Deficiency</strong>: Managed with amniotic membrane transplantation.</li>\n<li><strong>Corneal Opacity</strong>: Consider keratoplasty if stem cells are adequate.</li>\n<li><strong>Keratoprosthesis</strong>: For severely damaged eyes when keratoplasty isn't possible.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: History taking (Incorrect)</strong></p>\n<ul>\n<li>While history is important, <strong>immediate irrigation takes precedence</strong> in an emergency.</li>\n<li><strong>Delaying irrigation</strong> can worsen chemical penetration and damage.</li>\n</ul>\n<p><strong>Choice B: Vision measurement (Incorrect)</strong></p>\n<ul>\n<li>Visual acuity assessment is important but <strong>secondary</strong> to <strong>irrigation</strong>, as untreated chemical exposure can cause progressive damage.</li>\n</ul>\n<p><strong>Choice D: Administration of pain killers (Incorrect)</strong></p>\n<ul>\n<li>Pain management is necessary, but <strong>delaying irrigation for analgesia</strong> could worsen ocular damage.</li>\n<li><strong>Cycloplegics</strong> and <strong>topical anesthetics</strong> are used <strong>after initial irrigation</strong> to improve comfort.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>The first and most critical step in chemical eye injuries is immediate copious irrigation to remove the chemical agent and prevent further ocular damage.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinopathy of prematurity </span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinoblastoma</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Glaucoma </span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital cataract </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6 month-old baby, preterm at 33 weeks of gestation, is brought by parents with complaints of white pupillary reflex since two weeks. CT scan revealed calcification of the globe in both eyes. What is the diagnosis?</span></p>",
      "unique_key": "DT1318108",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318108,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Retinoblastoma </strong></p>\r\n<p>Retinoblastoma is a malignant tumor that develops in the retina of one or both eyes, most commonly in children. It is considered the most common intraocular tumor in childhood, with a prevalence of 1 in 15,000 to 20,000 live births.</p>\r\n<p><strong>Demographics:</strong></p>\r\n<ul>\r\n<li><strong>Age</strong>: Typically diagnosed in infancy and early childhood, usually between 1-2 years of age.</li>\r\n<li><strong>Sex</strong>: No gender predisposition.</li>\r\n<li><strong>Race</strong>: Less common in African children compared to Caucasians.</li>\r\n<li><strong>Bilateral Cases</strong>: Around 25-30% of cases have bilateral involvement.</li>\r\n</ul>\r\n<p><strong>Genetics:</strong></p>\r\n<ul>\r\n<li>The <strong>retinoblastoma gene</strong> (RB gene) located on chromosome 13 (13q14) is a tumor suppressor gene. Mutations or deletions of both alleles of this gene lead to retinoblastoma.</li>\r\n<li><strong>Hereditary cases</strong>: About 10% of retinoblastomas are inherited in an autosomal dominant manner.</li>\r\n<li><strong>Sporadic cases</strong>: 60% of cases occur due to somatic mutations, and 30% from germline mutations.</li>\r\n<li><strong>Germline mutations</strong>: The first mutation occurs in the gametes (eggs or sperm) and is passed down. These cases are more likely to be bilateral and may have associated non-ocular tumors, like osteosarcoma.</li>\r\n<li><strong>Somatic mutations</strong>: Both mutations occur post-fertilization, typically resulting in unilateral tumors.</li>\r\n</ul>\r\n<p><strong>Pathology:</strong></p>\r\n<ul>\r\n<li><strong>Origin</strong>: The tumor arises from the immature neural cells in the retina.</li>\r\n<li><strong>Histology</strong>: It is composed of small round blue cells with large nuclei. Features like <strong>Flexner-Wintersteiner rosettes</strong> are highly specific for retinoblastoma.</li>\r\n<li><strong>Microscopic Features</strong>: The tumor may show areas of necrosis and calcification.</li>\r\n</ul>\r\n<p><strong>Clinical Features:</strong></p>\r\n<ul>\r\n<li><strong>Intraocular Stage</strong>:\r\n<ul>\r\n<li><strong>Leukocoria</strong> (cat&rsquo;s eye reflex) is the most common presenting sign (60% of cases).</li>\r\n<li>Other signs include squint (strabismus), nystagmus (in bilateral cases), and defective vision (rare).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Painful Red Eye Stage</strong>:\r\n<ul>\r\n<li><strong>Acute secondary glaucoma</strong>, <strong>intraocular inflammation</strong> mimicking uveitis, and <strong>orbital cellulitis</strong> may occur if untreated.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Classifications:</strong></p>\r\n<ul>\r\n<li><strong>International Classification of Retinoblastoma (ICRB)</strong> is currently used to determine treatment:\r\n<ul>\r\n<li><strong>Group A</strong>: Very low risk; small tumors &lt;3 mm in greatest dimension.</li>\r\n<li><strong>Group B</strong>: Low risk; larger tumors or tumors near the fovea or optic disc.</li>\r\n<li><strong>Group C</strong>: Moderate risk; focal seeds or subretinal seeds.</li>\r\n<li><strong>Group D</strong>: High risk; diffuse seeds or larger tumors.</li>\r\n<li><strong>Group E</strong>: Very high risk; extensive involvement, including optic nerve and orbital extension.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Diagnosis:</strong></p>\r\n<ul>\r\n<li><strong>Examination under anesthesia</strong>: Includes full ophthalmoscopy, intraocular pressure measurement, and corneal diameter measurement.</li>\r\n<li><strong>Plain X-ray</strong>: Can show calcifications in 75% of cases.</li>\r\n<li><strong>Imaging</strong>: CT and MRI are used to assess tumor size, location, and possible metastasis.</li>\r\n<li><strong>Lactic Dehydrogenase (LDH)</strong>: Elevated levels in aqueous humor may indicate retinoblastoma.</li>\r\n</ul>\r\n<p><strong>Treatment:</strong></p>\r\n<ol>\r\n<li><strong>Chemotherapy</strong>: To reduce tumor size (chemoreduction), typically using carboplatin, vincristine, and etoposide (CVE regimen).</li>\r\n<li><strong>Focal Therapy</strong>: Depending on tumor size and location, treatments include cryotherapy, laser photocoagulation, and radiotherapy.</li>\r\n<li><strong>Enucleation</strong>: Preferred in cases with extensive tumors (Group E) or optic nerve involvement.</li>\r\n<li><strong>Palliative Therapy</strong>: For advanced cases with metastasis, includes chemoradiation, orbital exenteration, and external beam radiotherapy.</li>\r\n</ol>\r\n<p><strong>Prognosis:</strong></p>\r\n<ul>\r\n<li><strong>Untreated</strong>: The prognosis is poor, often resulting in death.</li>\r\n<li><strong>Enucleation before extraocular extension</strong>: Prognosis is better with a survival rate of 70-85%.</li>\r\n<li><strong>Poor Prognostic Factors</strong>: Optic nerve involvement, undifferentiated tumor cells, and extensive choroidal invasion.</li>\r\n</ul>\r\n<p><strong>Differential Diagnosis:</strong></p>\r\n<ul>\r\n<li>Conditions other than retinoblastoma that present as leukocoria (pseudoglioma) include:\r\n<ul>\r\n<li><strong>Congenital cataracts</strong>, <strong>retinopathy of prematurity</strong>, <strong>persistent hyperplastic primary vitreous</strong>, and others.</li>\r\n</ul>\r\n</li>\r\n<li>Endophytic retinoblastoma can be confused with <strong>tuberous sclerosis</strong>, <strong>neurofibromatosis</strong>, and other retinal tumors.</li>\r\n<li>Exophytic retinoblastoma must be differentiated from causes of exudative retinal detachment such as <strong>Coats' disease</strong>.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503111e863ab6-ae95-4bc6-9c81-4695603bf239.jpg\"><br>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025031149a7e81e-9da6-4752-aff6-d417abb58fe3.jpg\">\r\n<p><strong>Incorrect Choices Explanation:</strong></p>\r\n<p><strong>Choice A: Retinopathy of Prematurity (Incorrect)</strong></p>\r\n<ul>\r\n<li>Prematurity and leukocoria can be seen in <strong>ROP</strong>, but:\r\n<ul>\r\n<li><strong>No intraocular calcifications</strong> in ROP.</li>\r\n<li>ROP primarily affects the <strong>retinal vasculature</strong>, not forming a solid mass like retinoblastoma.</li>\r\n<li>Typically occurs in <strong>preterm infants</strong> with a history of <strong>oxygen therapy</strong>, which is not mentioned here.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Choice C: Glaucoma (Incorrect)</strong></p>\r\n<ul>\r\n<li>Glaucoma in infants (congenital glaucoma) presents with:\r\n<ul>\r\n<li><strong>Enlarged cornea (buphthalmos)</strong>, <strong>corneal haze</strong>, and <strong>epiphora</strong> (tearing).</li>\r\n<li><strong>Not leukocoria or calcification.</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Choice D: Congenital Cataract (Incorrect)</strong></p>\r\n<ul>\r\n<li>Congenital cataract can present with <strong>leukocoria</strong>, but:\r\n<ul>\r\n<li><strong>No calcifications</strong> on CT scan.</li>\r\n<li>Cataracts appear as <strong>lens opacity</strong> rather than a <strong>tumor mass</strong> with calcifications.</li>\r\n<li><strong>No association with retinoblastoma risk factors</strong> (like RB1 mutation).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>A 6-month-old preterm baby with leukocoria and bilateral intraocular calcifications on CT scan is highly suggestive of retinoblastoma, the most common intraocular childhood malignancy.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondria </span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Golgi complex </span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoplasmic reticulum </span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous discs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following does not form the inner component of photoreceptors? </span></p>",
      "unique_key": "DT1318115",
      "question_audio": null,
      "question_video": null,
      "map_id": 1318115,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Layers of Retina (Outer to Inner):</strong></p>\r\n<p><strong>1. Rods and Cones</strong>:</p>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>Located most externally, in contact with the pigment epithelium.</li>\r\n<li>Serve as the end-organs of vision.</li>\r\n</ul>\r\n<p><strong>&nbsp; &nbsp; Microanatomy:</strong></p>\r\n<ul style=\"list-style-type: circle;\">\r\n<li><strong>Outer Segment</strong>: Transductive region.</li>\r\n<li><strong>Inner Segment</strong>: Maintains cellular homeostasis.</li>\r\n<li><strong>Outer Nuclear Layer</strong>: Nuclear region.</li>\r\n<li><strong>Outer Plexiform (Synaptic) Layer</strong>: Transmissive region.</li>\r\n</ul>\r\n<p><strong>2. Rods</strong>:</p>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>Outer segments contain a boundary membrane with stacked discs.</li>\r\n<li>Discs are continuously renewed throughout life.</li>\r\n<li>New discs form near the inner segment and are gradually displaced toward the pigment epithelium.</li>\r\n<li>Old discs are eventually lost to the pigment epithelium.</li>\r\n</ul>\r\n<p><strong>3. Connection Between Inner and Outer Segments</strong>:</p>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>At the junction of the inner and outer segments, the cell body of rods and cones constricts.</li>\r\n<li>An eccentric connecting cilium links the inner and outer segments.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503112ddc81de-40ae-4019-914c-77a8cc093aaa.jpg\">\r\n<p><strong>Incorrect Choices Explanation:</strong></p>\r\n<p><strong>Choice A: Mitochondria (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Present in the inner segment</strong>, especially in the <strong>ellipsoid region</strong>.</li>\r\n<li>Provide <strong>ATP</strong> for photoreceptor function, particularly <strong>disc renewal and phototransduction</strong>.</li>\r\n</ul>\r\n<p><strong>Choice B: Golgi complex (Incorrect)</strong></p>\r\n<ul>\r\n<li>Found in the <strong>inner segment</strong>, primarily in the <strong>myoid region</strong>.</li>\r\n<li>Involved in <strong>protein modification and transport</strong>, essential for photoreceptor maintenance.</li>\r\n</ul>\r\n<p><strong>Choice C: Endoplasmic reticulum (Incorrect)</strong></p>\r\n<ul>\r\n<li>Located in the <strong>inner segment</strong> and plays a role in <strong>protein synthesis and lipid metabolism</strong>.</li>\r\n<li>Necessary for <strong>continuous renewal</strong> of photoreceptor components.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>The membranous discs are part of the outer segment of photoreceptors, whereas mitochondria, Golgi complex, and endoplasmic reticulum are components of the inner segment.</p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}